Phase 2 Study of Enzalutamide and GnRH Agonist Before, During and After Radiation Therapy in Treatment of Patients With High-risk Localized Prostate Cancer
Phase of Trial: Phase II
Latest Information Update: 09 Jun 2016
At a glance
- Drugs Enzalutamide (Primary) ; Leuprorelin
- Indications Prostate cancer
- Focus Adverse reactions
- 13 May 2014 According to the ClinicalTrials.gov record, status changed from not yet recruiting to recruiting.
- 06 Mar 2014 Planned End Date changed from 1 Apr 2017 to 1 Apr 2019 as reported by ClinicalTrial.gov record.
- 01 Mar 2014 New trial record